Matt Wilsey Overview
- Investor Type
-
Angel
- Status
-
Active
- Professionals
-
1

- Investments
-
5
- Portfolio
-
3
- Exits
-
2

Matt Wilsey General Information
Description
Mr. Matt Wilsey is a Co-Founder & serves as Chief Executive Officer at Grace Science. Mr. Wilsey serves as Board Member at Perlara. He is an Angel Investor. Matt is a Silicon Valley angel investor and advisor. He also serves as Secretary of the Board of Trustees at Charles and Helen Schwab Foundation Previously, Matt was Co-Founder and Chief Revenue Officer of CardSpring, a payment infrastructure company that was acquired by Twitter. Prior to CardSpring, Matt ran West Coast sales and business development for Howcast.com. He was responsible for building Howcast's instructional content library, distribution network, and strategic relationships. Before Howcast, Matt worked for Kohlberg Kravis Roberts (KKR) on the Capital Markets team focused on new product development, capital raising, and investor relations. Prior to that, Matt spent five years as Co-Founder and Vice President of Business Development at Zazzle.com, where he was responsible for all content and distribution deals. Matt holds a B.A. from Stanford University and a M.B.A. from Stanford's Graduate School of Business. In addition to the Grace Science Foundation, Matt is also a Board member at the Charles and Helen Schwab Foundation, The Lucile Packard Foundation for Children's Health, Global Genes, and the EveryLife Foundation for Rare Diseases.
Business Details
Investor Status
Primary Investor Type
Corporate Office
- Palo Alto, CA
- United States
Matt Wilsey Investments (5)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
---|---|---|---|---|---|---|
Glycomine | 16-Nov-2016 | Early Stage VC | Drug Discovery | Clinical Trials - Phase 2 | ||
Rinse | 09-Jun-2015 | Other Services (B2C Non-Financial) | Generating Revenue | |||
Perlara | 01-Apr-2015 | Drug Discovery | Generating Revenue | |||
Interior Define | 01-Sep-2014 | Seed Round | Home Furnishings | Generating Revenue | ||
Recursion Pharmaceuticals | 15-Aug-2014 | Seed Round | Drug Discovery | Generating Revenue/Not Profitable |
Matt Wilsey Exits (2)
Company Name | Exit Date | Exit Type | Exit Size |
---|---|---|---|
Interior Define | 27-Feb-2023 | Merger/Acquisition | |
Recursion Pharmaceuticals | 16-Apr-2021 |
Matt Wilsey Investments by Industry, Year, and Region
Matt Wilsey FAQs
-
Who is Matt Wilsey?
Matt Wilsey is an angel Investor who has made 5 investments.
-
What kind of investor is Matt Wilsey?
Matt Wilsey is an angel investor.
-
What does Matt Wilsey do?
As an angel investor, Matt Wilsey invests personal money into promising companies, typically in exchange for equity.
-
How many board seats does Matt Wilsey hold?
Matt Wilsey holds a board seat in Perlara.
-
What has Matt Wilsey invested in?
Matt Wilsey has made numerous investments in companies like Glycomine, Rinse, and Perlara within the Drug Discovery and Services (B2C Non-Financial) industries.
-
What has Matt Wilsey invested in recently?
Matt Wilsey's latest investment was on 16-Nov-2016 in Glycomine, a company within the Drug Discovery industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »